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A simple, reproducible, and rapid gas chromato­
graphic method for short-chain fatty acid determina­
tion in human feces was developed. It involves direct 
injection of fecal supernatants into the gas chromato­
graph, without any pretreatment. Contamination of 
the gas chromatographic column with nonvolatile fe­
cal material was prevented by the use of a glass liner 
in the injector. This liner, which acted as a precolumn, 
was stoppered with a glass wool plug at the lower end 
of the liner. Injection was performed against the glass 
wall of the liner, ensuring an immediate contact of the 
injected sample with the hot glass wall. More than 100 
injections of fecal supernatants could be carried out 
before the liner had to be replaced by a new one. Peak 
tailing and ghosting was prevented by the use of for­
mic acid in the fecal samples. The method gave sharp 
peaks with baseline separation for all the fatty acids.
© 1996 Academic Press, Inc.
Short-chain fatty acids (SCFA)2 are produced largely 
as a result of the breakdown of dietary carbohydrate in 
the gut by anaerobic bacterial fermentation (1). Acetic, 
propionic, and ¿7-butyric acid are quantitatively the 
most important ones. The SCFA present in minor 
amounts in the human colon (i-butyric, ^-valeric, i-va- 
leric, and i3-caproic acid (2)) primarily originate from 
protein catabolism and in particular from degradation 
of certain amino acids (3).
About 80-90% of the SCFA are absorbed; the rest 
are excreted in the feces (4, 5). Despite their presence 
in the colon in high millimolar concentrations, little 
information exists regarding the role of SCFA in health 
and disease (6-8). This is partly due to the fact that
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techniques to measure fecal SCFA concentrations are 
rather cumbersome and time-consuming. Most proce­
dures involve some kind of pretreatment of the fecal 
samples followed by gas chromatography (GC). Feces 
have been pretreated by extraction in organic solvents 
(9-11), ultrafiltration (12, 13), and derivatization (14, 
15), steam distillation (16), and vacuum distillation (3, 
17-19). At present, the latter method of vacuum dis­
tillation followed by GC of the aqueous SCFA solutions 
is used most often. Although GC on capillary columns 
has been used more and more, GC on packed columns 
is still the method of choice for the separation of fecal 
SCFA. In addition to GC, high-performance liquid chro­
matography has also been applied to the analysis of 
fecal SCFA (13, 20). A major drawback of the above- 
mentioned methods is the time-consuming pretreat­
ment procedures, e.g., for the vacuum distillation tech­
nique about 45 min are required for one complete 
analysis, Moreover, losses of the more volatile acids 
may occur during pretreatment. No methods were 
found whereby direct injection of human fecal superna­
tants into the gas chromatograph was applied, without 
using any pretreatment.
In the present study we describe a very simple, repro­
ducible, and rapid method for fecal SCFA determina­
tion, involving direct injection of fecal supernatants 
into the gas chromatograph, without any pretreatment.
MATERIALS AND METHODS 
Reagents
Formic acid, acetic acid (C2), propionic acid (C3), iso- 
butyric acid (i-C4), n~butyric acid (C4), isovaleric acid 
(jf-C5), /2-valeric acid (C5), n-caproic acid (C6), and 2- 
ethylbutyric acid (internal standard, IS), all analytical 
grade (> 97% purity) were obtained from Merck 
(Darmstadt, Germany). The column packing material, 
10% SP-1200/1% H 3PO4 on 80/100 Chromosorb W AW, 
came from Supelco (Bellefonte, PA). The glass wool (di~ 
methylchlorosilane treated) was from Chrompack
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(Middelburg, The Netherlands) and the small glass 
balls with a diameter of 1 mm were from Tamson (Zoet- 
ermeer, The Netherlands).
Preparation of Fecal Homogenate
Fresh fecal material was frozen on dry ice immedi­
ately after collection and stored at -20°C until pro­
cessing. Homogenates were prepared by suspending 10 
g of fecal material in 50 ml of distilled water, giving a 
16% (w/v) fecal suspension. One milliliter of the homo­
geneous suspension was transferred into a conical poly­
propylene micro sample tube (Eppendorf, 1 ml) and 
centrifuged for 1 min at lO^ OOOg'in an Eppendorf centri­
fuge. Ten microliters of a solution of 150 mmol/liter of
2-ethylbutyric acid (the gas chromatographic internal 
standard) in 100% formic acid was added to 100 pi of 
the supernatant in an Eppendorf tube (1 ml), resulting 
in a 9% formic acid suspension. This latter suspension 
was centrifuged for 1 min at 10,000gand 0,6-1.0 pi of 
the clear brownish supernatant was injected in the gas 
chromatograph for analysis. The final concentration of 
SCFA in the supernatant of the fecal homogenate 
(mmol/liter) must be multiplied by (5 + x) to obtain the 
concentration in the original feces in millimoles per 
kilogram wet weight and by (5 + a)/(1 -  x) to calculate 
the SCFA concentration in millimoles per kilogram dry 
weight. In this equation, x  represents the wet weight 
fraction of the feces. The wet weight fraction x  was 
determined by freeze-drying 5 g of the fecal samples. 
Using this method for 40 fecal samples, we obtained 
an x o f  0.76 ± 0.05 (mean ± SD; range, 0.65-0.85),
Preparation of Fecal Supernatant
Fecal samples were homogenized with a blender and 
ultracentrifuged for 2 h at 4°C and 30,000^. No fluid 
was added to the fecal sample for this homogenization. 
The supernatant was carefully removed. This fecal su­
pernatant fraction was stored at -20°C until analysis. 
For gas chromatographic analysis, 100 pi of fecal super­
natant was processed in the same manner as described 
above for fecal homogenate resulting in a clear dark- 
brown supernatant of which 0 .6-1 .0  pi was injected. 
The final concentration in the fecal supernatant (mmol/ 
liter) must be multiplied by the wet weight fraction x  
(about 0.75, see above) to obtain the concentration in 
the original feces in millimoles per kilogram wet weight 
and by (a/(  1-a)) to calculate the concentration in the 
original feces in millimoles per kilogram dry weight.
Gas Chromatography
The gas chromatograph used was a Chrompack Model 
CP 9001, equipped with a flame ionization detector and 
a CP-9010 automatic liquid sampler (Chrompack, Mid­
delburg, The Netherlands). The sample injection rate of
the auto injector was 50 ¡ills. Data handling was carried 
out with the Maestro chromatography data system 
(Chrompack). The injection port of the chromatograph 
was installed with a hand-made glass liner (length: 8 
cm; o.d. 6 mm; i.d. 3 mm) (Fig. 1A). This liner, which 
acted as a precolumn to prevent contamination of the 
chromatographic column with brown nonvolatile fecal 
material, was stoppered with a dimethylchlorosilane- 
treated glass wool plug. Injection was performed against 
the glass wall of the liner above the glass wool plug, by 
means of a 10-/zl Hamilton syringe with a slightly bent 
syringe needle, ensuring an immediate contact of the 
injected sample with the hot glass w all The results in 
this study were all obtained using the above-mentioned 
injection technique. During preparation of this article, a 
slight modification in injection technique was developed. 
For ensuring an immediate contact of the injected sam­
ple with hot glass, the liner was partly filled with small 
glass balls with a diameter of 1 mm. Injection was per­
formed by means of a I0~pl Hamilton syringe inside the 
liner between the glass balls, penetrating the glass balls 
by about 1 cm (Fig. IB).
The conditions were as follows; Column, 2 m X 2 mm
i.d., glass, packed with 10% SP 1200/1% H3P 0 4 on 80/ 
100 Chromosorb W AW; column temperature, 145°C; 
injection port temperature, 200°C; detector tempera­
ture, 180°C. The carrier gas was N2, 20 ml/min; H2, 30 
ml/min; air, 300 ml/min. Freshly packed columns were 
conditioned overnight at 190°C. A few l-pl injections 
of 10% formic acid were made to clear the column of 
unknown impurities. There was no need to regularly 
prime the column with formic acid or to add formic acid 
to the carrier gas.
Calibration and Recovery Studies
An aqueous stock standard (solution A) was prepared 
with a concentration of 250 mmol/liter for C2, 100 
mmol/liter for C3 , and 50 mmol/liter for C4, i-C4j C5t i- 
Cs, and C6. This stock solution was diluted 2,5-, 5-, 
10-, and 20-fold to obtain standard solutions B, C, D, 
and E, with concentrations ranging from 12.5 to 100 
mmol/liter for C2, 5 to 40 mmol/liter for C3, and 2.5 to 
20 mmol/liter for C4-C 6. To 100 pi of each standard 
solution 10 pi of a solution of 150 mmol/liter of 2-ethyl­
butyric acid (IS) in 100% formic acid was added. These 
standards were used for daily calibration. A linear rela­
tionship was found between the peak area ratio SCFA/ 
IS and concentration for each individual SCFA, The 
peak area responses in FID, although linear, differ for 
the different fatty acids. The peak areas relative to C4 
for equimolar amounts of the various SCFA amounted 
to 0.19 ± 0.01 for C2l 0.49 ± 0.01 for C3, 1.00 ± 0.02 
for i-C4l 0.94 ± 0.03 for both i-C5 and C5, and L01 ± 
0.05 for C6 (mean values ± SD, n = 8).
Recovery studies were performed from fecal superna-









FIG. 1. GC injection port. 1, Carrier gas flow; 2, injection port head retainer; 3, injection port head; 4, septum retaining cap; 5, septum;
6, O-ring; 7, (A) empty glass liner, provided with a glass wool plug at the end; (B) glass liner, stoppered with a glass wool plug and partly 
filled with small glass balls; 8, (A) 10-pl Hamilton injection syringe, provided with a slightly bent needle; (B) 10-^1 Hamilton injection 
syringe, penetrating the glass balls inside the liner by about 1 cm, during injection.
tant and from feces, Feces was processed as described 
above for fecal homogenate. Known amounts of SCFA 
were added to one fecal supernatant and to one fecal 
sample. After vortexing, the mixtures were kept at 
room temperature for 15 min and the clear fecal super- 
natants were analyzed by direct injection.
The intraassay reproducibility was determined for a 
standard SCFA solution and for a fecal supernatant by 
analyzing each sample eight times on the same day. 
For each gas chromatographic analysis, 100 pi of the 
sample was processed as described under preparation 
of fecal homogenate. The interassay reproducibility 
was determined by analyzing the same samples on 5 
different days, during a 3-month period. In between, 
the samples were stored at —20°C.
Vacuum Distillation of Fecal Samples
The recoveries obtained with the direct injection 
method (see above) were compared with those obtained 
after vacuum distillation. For vacuum distillation of 
fecal samples, we adapted the procedure as described 
earlier for serum (21). In short, to 3.0 ml of fecal super­
natant or fecal homogenate 0.3 ml of the IS solution 
(150 mmol/liter of 2-ethylbutyric acid in 100% formic 
acid) was added, resulting in a 9% formic acid solution 
(pH 2-2.5). After addition of one drop of 20% H3P 0 4, 
the mixture was vacuum distilled in an all-glass equip­
ment by means of a water suction pump. During this 
procedure, the sample was heated from room tempera­
ture to 70°C while the receiver tube was cooled in liquid 
nitrogen. Distillation was complete within 30 min. The 
clear colorless distillate was thawed and 0.6 -1 .0  pi was 
injected in the gas chromatograph for analysis.
Freeze-Drying of Fecal Samples
Five grams of feces was transferred into a glass vial 
of 15 ml. The feces was frozen by liquid nitrogen and
freeze-dried for 2 days, using a Hetosicc freeze-dryer 
(type CD 52, Heto InterMed, Birkerod, Denmark). The 
dry weight fraction was determined by weighing of the 
freeze-dried samples. The freeze-dried feces was made 
up with isotonic saline to the original weight of the 
feces sample, fecal supernatant was prepared, and the 
SCFA concentrations in the fecal supernatant of four 




Figure 2A shows a gas chromatogram of a standard 
mixture of the SCFA C2-C 6. A typical chromatogram 
of a fecal sample is shown in Fig. 3A. C2, C3, and C4 
are the main components in feces, whereas ƒ•C4, i-C5, 
C5, and C6 are present in minor concentrations. Base­
line separation was obtained for all the SCFA within 
4 min. The peaks are symmetrical without any tailing. 
Ghosting of peaks as described by van Eenaeme et a t 
(22) was minimized by the use of formic acid in the 
sample. As shown in Fig. 2B, ghosting was very small. 
Ghosting amounted to only 3-10% for C2 and 1-5%  
for for C3-C 6f depending on the state of the liner. A 
new liner gave somewhat less ghosting than a liner 
contaminated with fecal material after some 50-100  
injections. However, in all cases it was reduced to less 
than 1% after a second injection of 1 pi of 10% formic 
acid blank solution. Therefore, ghosting can be pre­
vented by injection of 1 pi of 10% formic acid blank 
solution in between two samples. When using auto­
mated injection, each fecal sample was followed by a 
blank solution. Both samples and blanks were injected 
twice, completely preventing ghosting and contamina­
tion of one sample with a previously injected one.
When performing injection into an empty liner, one 
should use a syringe with a slightly bent needle to ensure
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FIG. 2. (A) Gas chromatogram of a standard mixture of SCFA 
(standard solution B), Column temperature 145°C. Injection volume 
0.8 ¿¿I. (B) Gas chromatogram of a sample blank (0.8 y\ of a 9% formic 
acid solution), injected immediately after the standard sample shown 
in A (ghosting). Same detector attenuation as under A.
between the glass balls with a 10-pl Hamilton syringe, 
with the needle penetrating the glass balls by about 1 
cm. This injection technique has two advantages. First, 
no differences were observed between automated and 
hand injection. The glass balls largely increased the glass 
surface in the injection area and gave an evenly distrib­
uted contamination of the glass balls and the liner’s glass 
wall in the injection area, also during automated injec­
tion. Routinely, the liner was replaced after 100 injections 
of fecal samples. Second, this latter technique always 
ensures an immediate contact between sample and hot 
glass and always gave sharp resolved peaks, also in the 
case of a slowly performed injection as in Fig. 3B. The 
data presented here were all obtained using the first in­
jection technique, viz, injection by hand against the glass 
wall of an empty liner. However, the injection technique 
between glass balls gave exactly the same results. When 
comparing the concentrations of the various fatty acids 
obtained using injection between glass balls with those 
obtained with the first injection technique, excellent cor­
relations were seen (r = 0.9996-1.0000, n ~ 10, 5 stan­
dards and 5 fecal samples).
Recovery and Precision
Recoveries of the individual SCFA from spiked sam­
ples of fecal supernatant ranged between 92 and 102% 
and of feces between 95 and 102% (Table 1).
that the sample comes in immediate contact with the hot 
glass wall of the liner (Fig. 1A). If not, broad unresolved 
peaks were obtained (Fig. 3B), such as in the case of a 
slowly performed injection where immediately after injec­
tion the sample sticks at the end of the injection needle 
or after a normal injection with a straight needle where 
the sample was injected in the gas phase of the liner 
and not against the glass wall. This phenomenon was 
observed both for fecal samples and for the clear standard 
solutions. During injection of fecal samples, brown non­
volatile fecal material adheres onto the glass wall inside 
the liner in the injection area. This disturbs the gas chro­
matographic separation after more than about 100 injec­
tions by hand. This is first seen for the peak of Q which 
then broadens and begins to tail. If so, one must replace 
the glass liner by a new one, which can be done within 
1 min. Using automated injection, tailing of the C2 peak 
was already observed after about 40 injections. During 
automated injection the sample was always injected in 
exactly the same way, thereby contaminating the wall of 
the glass liner at only one spot. The injection area became 
therefore sooner contaminated than when using injection 
by hand, the latter resulting in a more evenly distributed 
contamination.
An alternative injection technique is the use of a liner, 
partly filled with small glass balls with a diameter of 1 




















FIG. 3. (A) Gas chromatogram of a fecal supernatant. Column tem­
perature 145°C. Injection volume 0.8 pi. (B) Gas chromatogram of 
the same fecal supernatant as in A, injected more slowly than under 
A with a rate of 1 /¿I/s, and using injection in the gas phase of an 
empty liner.
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TABLE 1
Recovery of SCFA from One Fecal Supernatant and from One Fecal Sample, Spiked with Different Amounts of SCFA
Acetic Propionic ./-Butyric /7-Butyric /-Valeric /3-Vaîeric /7-Caproic
acid acid acid acid acid acid acid
Fecal supernatant (mmol /I iter)
Original amount 22.8 3.6 0.5 1.5 1.3 0.5 1.0
Amount added 25.0 10.0 5.0 5.0 5.0 5.0 5.0
Amount recovered 44.5 13.1 5.6 6.3 6.0 5.5 5.7
Recovery (%) 93 96 102 97 95 100 95
Amount added 50.0 20.0 10.0 10.0 10.0 10.0 10.0
Amount recovered 71.5 23.3 10.3 11.2 11.2 10.1 10.6
Recovery (%) 98 99 98 97 99 96 96
Amount added 75.0 30.0 15.0 15.0 15.0 15.0 15.0
Amount recovered 90.3 33.0 15.1 15.8 15.5 14.5 16.3
Recovery (96) 92 98 97 96 95 94 102
Feces (mmol/kg wet weight)
Original amount 37.5 8.6 0.9 7.6 1.9 1.6 1.9
Amount added 125.0 50.0 25.0 25.0 25.0 25.0 25.0
Amount recovered 161.8 59.8 26.2 27.0 26.4 25.8 25.6
Recovery (96) 100 102 101 98 98 97 95
The intraassay and interassay reproducibility was 
excellent (Table 2), with very low variation coefficients. 
The interassay reproducibility was determined by ana­
lyzing the same samples on 5 different days, during a
3-month period. In between, the samples were stored 
at -20°C. The low interassay variation shows that 
samples can be stored at -20°C without any change in 
SCFA concentrations.
Once the samples have been prepared for GC injec­
tion, viz. after addition of the internal standard in for­
mic acid, they are quite stable. Storage for 6 months 
at 4 or —20°C and for 1 week at room temperature 
showed no change in SCFA concentrations.
The detection limit amounted to 0.1 mmol/liter for 
C2 and to 0.02-0.05 for C3-C 6, which is suitable for 
the analysis of fecal samples.
TABLE I
The Intraassay and Interassay Reproducibility, as Measured for One Fecal Supernatant (Sample A)















Intraassay for sample A 
Concentration (mmol/liter), 
mean ± SD (n -  8) 80.6 ± 2.2 23.8 ± 0.5 2.2 ± 0.2 13.6 ± 0.3 3.7 £  0.2 3.0 ± 0.1 1.0 ± 0.1
CVa (96) 2.7 2.1 9.1 2.2 5.4 3.3 10.0
Intraassay for sample B 
Concentration (mmol/liter), 
mean ± SD (/i = 8) 50.9 ± 1.3 22.5 ± 0.5 11.2 ± 0.2 11.2 ± 0.3 10.1 ± 0.2 11.4 ± 0.2 10.8 ± 0.2
CV (%) 2.6 2.2 1.8 2.7 2.0 1.8 1.9
Interassay for sample A 
Concentration (mmol/liter), 
mean ± SD {n = 8) 78.6 ± 3.3 24.3 ± 0.4 2.4 ± 0.1 14.1 ± 0.2 3.9 ± 0.2 3.1 ± 0.1 1.1 ± 0.1
CV (96) 4.2 1.6 4.2 1.4 5.1 3.2 9.1
Interassay for sample B 
Concentration (mmol/liter), 
mean ± SD (n = 8) 51.1 ± 1.5 22,7 ± 0.5 11.3 ± 0.2 11.3 ± 0.2 10.1 ± 0.2 11.2 ± 0.2 10.7 ± 0.4
CV (96) 2.9 2.2 1.8 1.8 2.0 1.8 3.7
a Coefficient of variation.
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mean ± SD 
(n ^  24) 74.1 ±  27.6 22.4 ± 10.8 1.9 ± 1.0 13.6 ± 6.2 3.4 ± 2.1 2.8 ± 3.1 1.3 ± 1.0 119.5 ±  44.9
Range (mmol/liter) 25.0-121.5 6.2-47.6 0.6-5.0 3.2-28.5 1.0-10.2 0.8-5.1 0,0-3.4 37.7-■202.7
Percentage of total, 
mean £  SD 
(n = 24)
Range (%)
62.1 ± 4.7 
50.2-70.4
18.4 ± 3.5 
13.3-26.5
1.7 ± 0.7 
0.5-2.8
11.2 ± 2.1 
8.3-15.3
3.2 ± 1.7 
0.6-6.1
2.4 ± 0.5 
1.3-3.2
1.0 ± 0,6 
0.0-2.5
Concentration of SCFA in Fecal Supernatant
The characteristics of the SCFA concentrations in 
human fecal supernatant are depicted in Table 3. Ace­
tic acid, propionic acid, and /3-butyric acid are quantita­
tively the most important ones and constitute about 
90% of intestinal SCFA in molar ratios of ca. 68:20:12.
Freeze-Dried Fecal Samples
Concentrations of SCFA after freeze-drying were 
compared with those before freeze-drying. Recoveries 
after freeze-drying were almost quantitative (mean ±
SD, n  = 4: C2, 1 0 1  ± 1 0 ; C3, 93 ± 7; i-C4t 90 ± 3; C4, 
91 ± 7; /-C5, 91 ± 7; C5, 93 ±  9; C6, 101 ± 3), Almost 
no losses of SCFA were observed during freeze-drying 
of fecal samples. The pH as measured in 40 fecal super- 
natants amounted to 6.50 ± 0.24 (range 6.1 to 6.9). The 
pjKa of the SCFA (4) is approximately 4.8, Thus, at fecal 
pH the SCFA are in ionized nonvolatile form for more 
than 95%, explaining the almost quantitative recovery 
after freeze-drying. One might also make the samples 
alkaline before freeze-drying to prevent any loss of 
SCFA during lyophilization (15).
Comparison of the Direct Injection Method with the
Vacuum Distillation Method
The direct injection technique as described in this 
paper was compared with the most often used tech­
nique of vacuum distillation, for three samples, one 
fecal supernatant, a fecal homogenate 1 , and a fecal 
homogenate 2, the latter spiked with stock solution A 
(2 vol of fecal homogenate and 1 vol of solution A). The 
absolute peak areas before and after vacuum distilla­
tion were compared, to assess potential losses of SCFA 
during vacuum distillation. The thus obtained absolute 
recoveries are shown in Table 4. The most volatile 
SCFA C2 and C3 showed a loss of, respectively, 20-30  
and 15-25% during vacuum distillation, whereas the 
loss of the higher SCFA C4-C 6 amounted to only 0 -
10%. Of course, these losses are accounted for when 
vacuum-distilled standards are used.
DISCUSSION
Many pitfalls have been found in the gas chromato­
graphic analysis of SCFA (23, 24) such as peak tailing 
due to adsorption, ghost peaks after repeated injec­
tions, double peak formation, azeotrope formation, or 
dimerization and loss by evaporation during prechro­
matographic manipulations. Van Eenaeme et al. (22) 
stated that the injection area which includes the injec­
tor, the column plugs, and the column top might be the 
principle cause of ghosting. The results in the present 
paper show that this also holds for the phenomena of 
peak tailing, peak broadening, and double peak forma­
tion. All these disturbances can be prevented by using 
formic acid in the injected sample and by using the 
technique of injection against the hot glass wall of an 
empty liner or by using injection between glass balls 
in a glass liner, the liner acting as a precolumn. Injec­
tion of the sample against hot glass appears to be very 
important for obtaining sharp peaks. Broad unresolved 
peaks were seen after injection in the gas phase of an 
empty liner. This might be explained by a temperature 
difference. The glass wall of the liner and the glass 
balls have about the same temperature as the injector 
(200°C), whereas the temperature in the gas phase of 
the liner is surely lower, mainly due to cooling by the 
N2 carrier gas stream through the liner. Injection in 
the gas phase might therefore result in a slower evapo­
ration of the sample and as a consequence of that in 
peak broadening.
With the technique described in the present study, 
fecal samples can be analyzed by GC without any pre­
treatment, The use of a precolumn protects the GC 
column against serious contamination with nonvolatile 
fecal material. The same gas chromatographic column 
is now in use for about 3 years for fecal SCFA. Despite 
a brown coloring of the first part of the column after 
some 10,000  injections of fecal samples, the retention
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TABLE 4
Absolute Recovery of SCFA after Vacuum Distillation of a Fecal Supernatant, of a Fecal Homogenate 1















Fecal supernatant (mmol/llter) 64.2 14.4 0.6 27.9 0.6 1.4 3.5
Absolute recovery (%) 82 87 90 90 95 94 103
Fecal homogenate 1 (mmol/liter) 22.7 4.0 0.3 4.3 0.2 0.6 0.7
Absolute recovery (%) 71 75 90 90 100 90 100
Fecal homogenate 2 (mmol/llter) 111.5 41.7 19.2 22.8 17.1 19.2 16.8
Absolute recovery (%) 75 85 92 90 94 93 103
times of the SCFA remained stable and no deteriora­
tion of the column was observed, again stressing the 
fact that the injection technique is more important for 
a good separation than the condition of the column.
The use of about 10% formic acid in the injection 
sample is completely safe as was also shown by Coch­
rane (23), No corrosion of the metal parts of the gas 
chromatograph was observed, not even after 10 years.
In the previous literature about GC analysis of SCFA 
in aqueous solution, it was very common to add phos­
phoric acid to the glass wool and/or to the sample (21, 
23-25). In the present study, we used dichlorodimeth- 
ylsilane-treated glass wool in the liner. However, differ­
ent forms of glass wool (untreated, phosphoric acid- 
treated, and silanized) all gave the same results when 
injecting 9% formic acid test samples (data not shown), 
eliminating any influence of the glass wool on the SCFA 
separation in our setting , As previously reported (21- 
23), the use of formic acid as injection solvent is essen­
tial to prevent the adsorption of SCFA in the column, 
thereby eliminating peak tailing and ghosting. Another 
advantage of the use of formic acid in the sample is 
the high stability of the SCFA-end solutions, this in 
contrast to, e.g., phosphoric acid-end solutions, the lat­
ter resulting in a substantial reduction of SCFA within 
30 min at room temperature, due probably to micellar 
separation (21). Compared with the volatile formic 
acid, use of the nonvolatile phosphoric acid will also 
result in a faster contamination of the injection area, 
resulting in peak broadening.
In the past, direct injection of urine onto the GC 
column was used to measure the SCFA in urine (26). 
No recovery and precision were determined in that 
study. The life span of the column was very shortened, 
due to contamination of nonvolatile compounds onto 
the column. The present method of direct injection in 
a glass precolumn may also be used for measuring 
SCFA in other biological fluids, e.g. in urine.
The fecal SCFA concentrations in normal healthy 
subjects found in this study were similar to those found 
by other groups (6, 13, 18, 20, 27-29) but were about 
twice as high as those found by Scheppach et al. (19).
We have no obvious explanation for this discrepancy. 
Acetic, propionic, and /z-butyric acid are quantitatively 
the most important ones and constitute about 90% of 
intestinal SCFA in a molar ratio of 68:20:12.
In conclusion, the direct injection method as pre­
sented in this paper is a rapid, sensitive, and reliable 
procedure for measuring fecal SCFA. When analyzing 
fecal homogenates, one SCFA analysis requires only 10 
min, including sample preparation time. This opens 
the possibility of analyzing many samples in a short 
time, facilitating research in this field.
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